Gut microbiota dysbiosis induces tryptophan metabolite alterations leading to CD progression, which is mainly based on reduced indole derivatives and AhR activity (Monteleone et al., 2011; Nikolaus et al., 2017). This evidence concerns the gene AHR and Cowden disease.